Breastfeeding women in need of information about antiemetics for nausea and vomiting during pregnancy: a review of inquiries to a medicines information service
- PMID: 38094894
- PMCID: PMC10716413
- DOI: 10.3389/fphar.2023.1238875
Breastfeeding women in need of information about antiemetics for nausea and vomiting during pregnancy: a review of inquiries to a medicines information service
Abstract
Introduction: The medicines information service, SafeMotherMedicine, regularly receives inquiries from breastfeeding women asking about antiemetics for nausea and vomiting during pregnancy (NVP) or hyperemesis gravidarum (HG). However, treatment guidelines for NVP or HG do not address the use of antiemetics in women who are breastfeeding while becoming pregnant again. Our objective was to characterize inquiries to describe the need for lactation risk information among women with NVP or HG and also to raise awareness of this topic. Method: We conducted a review of inquiries to the Norwegian web-based medicines information service, SafeMotherMedicine. Results: In total, 97 inquiries addressing the use of antiemetics for NVP or HG during breastfeeding were identified. The following medications were addressed in the inquiries (n = 97): meclizine (51%), metoclopramide (33%), promethazine (16%), ondansetron (9%), and others (6%). The breastfed child was older than 6 months and 1 year in 96% and 71% of the inquiries, respectively. There was a preponderance of general inquiries (unclear motivation/double checking) (64%); however, one-third of the inquiries were generated by restrictive information from sources such as product information. Conclusion: Based on our small review of spontaneous inquiries, there seems to be an information need about the use of antiemetics during lactation among women breastfeeding an older infant whilst suffering from NVP or HG. Addressing such use in guidelines for NVP and HG and/or other easily available information sources may be considered in order to balance out the restrictive information provided by the manufacturers. This could avoid potential unnecessary weaning of breastfeeding in an otherwise challenging situation.
Keywords: breastfeeding; hyperemesis gravidarum; medicine safety; medicines information; nausea and vomiting during pregnancy.
Copyright © 2023 Heitmann, Bakkebø, Havnen and Schjøtt.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review and economic assessment.Health Technol Assess. 2016 Oct;20(74):1-268. doi: 10.3310/hta20740. Health Technol Assess. 2016. PMID: 27731292 Free PMC article. Review.
-
Clinical management of nausea and vomiting in pregnancy and hyperemesis gravidarum across primary and secondary care: a population-based study.BJOG. 2019 Sep;126(10):1201-1211. doi: 10.1111/1471-0528.15662. Epub 2019 Mar 27. BJOG. 2019. PMID: 30786126
-
Identifying target areas of medicines information efforts to pregnant and breastfeeding women by reviewing questions to SafeMotherMedicine: A Norwegian web-based public medicines information service.BMC Pregnancy Childbirth. 2022 Dec 2;22(1):893. doi: 10.1186/s12884-022-05252-3. BMC Pregnancy Childbirth. 2022. PMID: 36461026 Free PMC article.
-
Interventions for treating hyperemesis gravidarum: a Cochrane systematic review and meta-analysis.J Matern Fetal Neonatal Med. 2018 Sep;31(18):2492-2505. doi: 10.1080/14767058.2017.1342805. Epub 2017 Jul 11. J Matern Fetal Neonatal Med. 2018. PMID: 28614956 Review.
-
Treatment of nausea and vomiting during pregnancy -a cross-sectional study among 712 Norwegian women.Eur J Clin Pharmacol. 2016 May;72(5):593-604. doi: 10.1007/s00228-016-2012-6. Epub 2016 Jan 27. Eur J Clin Pharmacol. 2016. PMID: 26815908
References
-
- Breastfeeding and Medication (2023). Breastfeeding an older baby whilst experiencing Hyperemesis. Available at: https://breastfeeding-and-medication.co.uk/wp-content/uploads/2023/02/hy....
-
- E-lactancia (2023). Doxylamine. Meclizine. Metoclopramide. Promethazine. Prochlorperazine. Ondansetron. Available at: https://www.e-lactancia.org/ (Accessed May 19, 2023).
-
- Hale T. W., Krutsch K. (Editors) (2023). Medications and mothers milk. 20th ed, 226–227. 411, 438-40, 494, 543, 545.
LinkOut - more resources
Full Text Sources